CD59 mRNA transcription analysis reveals that multiple cancers, such as diffuse large B cell lymphoma (DLBC), glioblastoma multiforme (GBM), pancreatic adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), and thymoma (THYM) exhibit significantly higher mRNA expression of CD59 (Figure 1B). The gene discussed is CD59; the disease is cutaneous melanoma.